How it works
Survodutide acts as a dual GLP-1 and GCGR receptor agonist. It reduces appetite, delays gastric emptying, increases energy expenditure, and enhances insulin secretion. These effects result in weight reduction and improved glucose control.
Recommended for:
- Patients with type 2 diabetes
- Individuals with obesity and metabolic syndrome
- Those requiring weight reduction when diet and exercise are insufficient
- Patients with cardiovascular risks
Clinical evidence:
- Phase II studies demonstrated 15–20% body weight reduction in obese patients.
- Proven efficacy in glycaemic control in type 2 diabetes.
- Additional benefits include improved lipid profile and reduction of visceral fat.
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)
